Patients with human epidermal growth factor receptor 2 (HER2)–positive early breast cancer with residual invasive disease after neoadjuvant systemic therapy have a high risk of recurrence and death.

The abstract summarizes positive results from the U.S. multi-site NEXICART-2 trial evaluating NXC-201 in relapsed/refractory AL Amyloidosis with a data cutoff of January 28, 2025. On June 3 ...

and many editorial decisions are based on the abstract alone. Positive results are also more likely to be published in the first place, the paper notes, citing one study that found 15 percent of peer ...

Most patients requiring mechanical ventilation for acute lung injury and the acute respiratory distress syndrome (ARDS) receive positive end-expiratory pressure (PEEP) of 5 to 12 cm of water.

The data is included in an abstract for a moderated poster presentation that will be presented by Bruce Sands, M.D., M.S., at United European Gastroenterology Week (UEGW) 2023 in Copenhagen ...